发明名称 NON-AQUOSITY COLON PURGATIVE FORMULATION
摘要 PROBLEM TO BE SOLVED: To provide an effective dosage formulation of a colon purgative easily and comfortably administerable. SOLUTION: The colon purgative formulation can be administered orally and used for bringing partial or complete dejection of colon of mammal. The formulation substance comprises a non-aqueous mixture of a purgative salt selected from the group consisting of Mg<SB>3</SB>(PO<SB>4</SB>)<SB>2</SB>, MgHPO<SB>4</SB>, Mg(H<SB>2</SB>PO<SB>4</SB>)<SB>2</SB>, MgSO<SB>4</SB>, MgCl<SB>2</SB>, Na<SB>2</SB>SO<SB>4</SB>, sodium tartrate, potassium tartrate, magnesium tartrate and mixtures thereof, and is administered at an effective concentration of the purgative in the form of a tablet or capsule. Preferably, at least one kind of magnesium phosphate (more preferably dibasic magnesium phosphate) is used. Another preferable embodiment includes an addition of a binder, a dispersing agent and a buffering agent. These do not impart a malinfluence to the osmotic pressure or effectiveness of the purgative formulation. COPYRIGHT: (C)2004,JPO
申请公布号 JP2004043489(A) 申请公布日期 2004.02.12
申请号 JP20030297910 申请日期 2003.08.21
申请人 INKINE PHARMACEUTICAL CO INC 发明人 JACOB LEONARD S;WILLIAMS TAFFY J;KRELL ROBERT D
分类号 A61K9/20;A61K9/48;A61K31/00;A61K31/12;A61K31/122;A61K31/19;A61K31/194;A61K31/235;A61K33/04;A61K33/06;A61K33/08;A61K33/10;A61K33/14;A61K33/42;A61P1/00;A61P1/10;(IPC1-7):A61K33/14 主分类号 A61K9/20
代理机构 代理人
主权项
地址